helthgene
Skip to content
$3,280.00
Reservation Deposit: HK$200.
Check Up Location:
AM Session: Tsim Sha Tsui, or Jordan.
PM Session: Tsim Sha Tsui only.
*Suite 1424-1425, 14/F, Ocean Centre, 5 Canton Road, Tsim Sha Tsui, Kowloon✅ Accept Elderly Health Care Voucher Scheme.
*18/F, 238 Nathan Road, Jordan, Kowloon ❌Not Accept: Elderly Health Care Voucher Scheme, Octopus Card, WeChat Pay, Alipay HK.
In addition, you can upgrade for an extra HK$199 to receive a 35 items health check-up package (details can be found in the image below). If ordering online, please indicate in the remarks that you wish to add the HK$199 health check package. Thank you.
*Offers are non-transferable. *
*Health Gene Limited reserves the right of final decision in case of any disputes. *
For Men Only:
For Women Only:
A tumor marker is a biomarker found in blood, body tissues, or urine, which can be produced by cancer cells or normal cells in response to cancer in the body.
While some tumor markers are linked to a specific cancer type, others are found in various types of cancers.
NSE is a glycolytic enzyme specific to neurons and neuroendocrine cells. It is used to monitor diseases that damage neuroendocrine cells, primarily serving as a marker for neuroblastoma and small cell lung cancer.
The application of M2-PK as a tumor marker is becoming increasingly widespread and advanced, commonly used for the diagnosis and monitoring of various malignant diseases. Tumor M2-PK has been shown to have high sensitivity in pancreatic cancer, gastric cancer, esophageal cancer, colorectal cancer, and cholangiocarcinoma. When used in conjunction with traditional tumor markers, it is particularly effective in detecting early colorectal cancer.
This blood gene test detects the presence of Epstein-Barr (EB) virus infection. Most nasopharyngeal carcinoma patients have EB virus antibodies in their serum, making it the most common test for nasopharyngeal carcinoma. It can screen for early nasopharyngeal carcinoma and is widely used in Hong Kong hospitals. A negative result indicates no current infection, while a positive result suggests EB virus infection, warranting a detailed examination with nasopharyngeal endoscopy.
CEA is a common tumor marker for colorectal cancer. Elevated levels of CEA can also be seen in patients with other cancers such as lung cancer, breast cancer, thyroid cancer, pancreatic cancer, liver cancer, gastric cancer, ovarian cancer, and bladder cancer.
The ratio of Pepsinogen I (PGI) reflects the condition of the gastric fundus and body mucosa, aiding in the detection of gastritis and gastric cancer. The ratio of Pepsinogen II (PGII) reflects the state of the entire gastric gland, duodenum, prostate, and pancreas, helping in the examination of gastritis and gastric cancer.
The level of Gastrin-17 helps detect abnormal gastric acid secretion or gastritis, making it an important reference for early detection of gastric diseases and precancerous conditions. Gastrin-17, secreted by G cells in the gastric antrum, promotes gastric acid secretion, gastrointestinal mucosal growth, and regulation of the esophageal sphincter, playing a crucial role in maintaining digestive tract function and integrity. It is included in early gastric cancer screening projects along with Pepsinogen I, Pepsinogen II, and their ratios.
Healthy individuals may have small amounts of CA 19.9 in their blood. Elevated levels are typically indicative of pancreatic cancer, though they can also suggest other types of cancer or non-cancerous conditions such as cirrhosis, cholangiocarcinoma, and gallbladder cancer.
CA 72.4 is used to test for pancreatic cancer, colorectal cancer, breast cancer, and ovarian cancer, with a high sensitivity for gastric cancer, making it a common reference marker for this condition when combined with other tests.
AFP testing in blood helps diagnose liver cancer.
AFP levels are high at birth but decrease to very low levels by age one. Healthy adults should have very low AFP levels. Elevated AFP levels may indicate liver cancer, ovarian cancer, testicular cancer, or liver diseases such as cirrhosis and hepatitis.
The PSA test measures the level of prostate-specific antigen in the blood, a marker for prostate cancer.
The prostate is a small gland in the male reproductive system located below the bladder, producing fluid that is part of semen. Normally, men have low PSA levels in their blood. High PSA levels can indicate prostate cancer but may also suggest non-cancerous prostate conditions such as infections or benign prostatic hyperplasia.
Beyond its use as a pregnancy marker, β-HCG testing is primarily used to diagnose trophoblastic diseases and germ cell tumors (testicular cancer).
Cancer antigen CA 15.3 is a protein produced by normal breast cells. However, many patients with breast tumors show elevated levels of CA 15.3 and cancer antigen 27.29. CA 15.3 is released by tumor cells into the bloodstream, and thus measuring CA 15.3 levels in the blood can be used to track tumors. For accurate results, it should be analyzed in conjunction with other diagnostic tests. The CA 15.3 test is primarily used to monitor the response to breast cancer treatment and to help observe the recurrence of breast cancer. Generally, higher CA 15.3 levels indicate more advanced stages of breast cancer and a greater number of cancer cells (tumor cells). As the cancer progresses, the concentration of CA 15.3 usually increases. In metastatic breast cancer, high levels of CA 15.3 are often seen when the cancer has spread to bones or the liver. However, normal CA 15.3 levels do not guarantee the absence of localized or metastatic breast cancer, thus CA 15.3 should only be used as an auxiliary tool in breast cancer diagnosis.
The most significant risk factor for ovarian cancer is a hereditary genetic mutation in one of two genes: breast cancer gene 1 (BRCA1) or breast cancer gene 2 (BRCA2). Measuring the levels of the protein CA 125 in the blood can help in the detection of ovarian cancer, and is also used to monitor the response to cancer treatment during and after therapy. Various conditions can cause elevated CA 125 levels, including normal conditions (such as menstruation) and non-cancerous conditions (such as uterine fibroids). Certain cancers can also lead to elevated CA 125 levels, including ovarian cancer, endometrial cancer, peritoneal cancer, and fallopian tube cancer.
Booking Procedure
For more details, please click on Check-up items.
| Cancer Screening | Neuron Specific Enolase |
|---|---|
| For Men Only | 1. Prostatic Specific Antigen (PSA), Total |
| For Women Only | 1. CA15.3 |
